Pashupati Prasad Mishra

Pashupati Prasad Mishra

Auto-generated profile, based on publicly available information

Pashupati Prasad Mishra

Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LSLifelines Cohort Study
Lifelines Cohort Study
MWMatthias Wuttke
Matthias Wuttke
VPV. A. Million Veteran Program
V. A. Million Veteran Program
YLYong Li
Yong Li
MLMan Li
Man Li
CPCristian Pattaro
Cristian Pattaro
Chronic kidney disease (CKD) is responsible for a public health burden with multi-systemic complications. Through trans-ancestry meta-analysis of genome-wide association studies of estimated glomerular filtration rate (eGFR) and independent replication (n = 1,046,070), we identified 264 associated loci (166 new). Of these, 147 were likely to be relevant for kidney function on the basis of associations with the alternative kidney function marker blood urea nitrogen (n = 416,178). Pathway and enrichment analyses, including mouse models with renal phenotypes, support the kidney as the main target organ. A genetic risk score for lower eGFR was associated with clinically diagnosed CKD in 452,264 independent individuals. Colocalization analyses of associations with eGFR among 783,978 European-ancestry individuals and gene expression across 46 human tissues, including tubulo-interstitial and glomerular kidney compartments, identified 17 genes differentially expressed in kidney. Fine-mapping highlighted missense driver variants in 11 genes and kidney-specific regulatory variants. These results provide a comprehensive priority list of molecular targets for translational research.

2 October 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
GSGerman Chronic Kidney Disease Study
German Chronic Kidney Disease Study
ATAdrienne Tin
Adrienne Tin
LSLifelines Cohort Study
Lifelines Cohort Study
VPV. A. Million Veteran Program
V. A. Million Veteran Program
JMJonathan Marten
Jonathan Marten
AKAnna Köttgen
Anna Köttgen

14 April 2019 in Aging
Verified
Journal Article
Open access
Giovanni FioritoGiovanni Fiorito
Giovanni Fiorito
TCthe BIOS Consortium
the BIOS Consortium
TCthe Lifepath consortium
the Lifepath consortium
CMCathal McCrory
Cathal McCrory
OROliver J Robinson
Oliver J Robinson
SPSilvia Polidoro
Silvia Polidoro
Differences in health status by socioeconomic position (SEP) tend to be more evident at older ages, suggesting the involvement of a biological mechanism responsive to the accumulation of deleterious exposures across the lifespan. DNA methylation (DNAm) has been proposed as a biomarker of biological aging that conserves memory of endogenous and exogenous stress during life.We examined the association of education level, as an indicator of SEP, and lifestyle-related variables with four biomarkers of age-dependent DNAm dysregulation: the total number of stochastic epigenetic mutations (SEMs) and three epigenetic clocks (Horvath, Hannum and Levine), in 18 cohorts spanning 12 countries.The four biological aging biomarkers were associated with education and different sets of risk factors independently, and the magnitude of the effects differed depending on the biomarker and the predictor. On average, the effect of low education on epigenetic aging was comparable with those of other lifestyle-related risk factors (obesity, alcohol intake), with the exception of smoking, which had a significantly stronger effect.Our study shows that low education is an independent predictor of accelerated biological (epigenetic) aging and that epigenetic clocks appear to be good candidates for disentangling the biological pathways underlying social inequalities in healthy aging and longevity.

21 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
INIoanna Ntalla
Ioanna Ntalla
LWLu-Chen Weng
Lu-Chen Weng
JCJames H. Cartwright
James H. Cartwright
AHAmelia Weber Hall
Amelia Weber Hall
GSGardar Sveinbjornsson
Gardar Sveinbjornsson
PMPatricia B. Munroe
Patricia B. Munroe
The electrocardiographic PR interval reflects atrioventricular conduction, and is associated with conduction abnormalities, pacemaker implantation, atrial fibrillation (AF), and cardiovascular mortality. Here we report a multi-ancestry (N = 293,051) genome-wide association meta-analysis for the PR interval, discovering 202 loci of which 141 have not previously been reported. Variants at identified loci increase the percentage of heritability explained, from 33.5% to 62.6%. We observe enrichment for cardiac muscle developmental/contractile and cytoskeletal genes, highlighting key regulation processes for atrioventricular conduction. Additionally, 8 loci not previously reported harbor genes underlying inherited arrhythmic syndromes and/or cardiomyopathies suggesting a role for these genes in cardiovascular pathology in the general population. We show that polygenic predisposition to PR interval duration is an endophenotype for cardiovascular disease, including distal conduction disease, AF, and atrioventricular pre-excitation. These findings advance our understanding of the polygenic basis of cardiac conduction, and the genetic relationship between PR interval duration and cardiovascular disease.

20 June 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NMNina Mononen
Nina Mononen
LLLeo-Pekka Lyytikäinen
Leo-Pekka Lyytikäinen
ISIlkka Seppälä
Ilkka Seppälä
PMPashupati P. Mishra
Pashupati P. Mishra
MJMarkus Juonala
Markus Juonala
EREmma Raitoharju
Emma Raitoharju
We analyzed the associations between whole blood microRNA profiles and the indices of glucose metabolism and impaired fasting glucose and examined whether the discovered microRNAs correlate with the expression of their mRNA targets. MicroRNA and gene expression profiling were performed for the Young Finns Study participants (n = 871). Glucose, insulin, and glycated hemoglobin (HbA1c) levels were measured, the insulin resistance index (HOMA2-IR) was calculated, and the glycemic status (normoglycemic [n = 534]/impaired fasting glucose [IFG] [n = 252]/type 2 diabetes [T2D] [n = 24]) determined. Levels of hsa-miR-144-5p, -122-5p, -148a-3p, -589-5p, and hsa-let-7a-5p associated with glycemic status. hsa-miR-144-5p and -148a-3p associated with glucose levels, while hsa-miR-144-5p, -122-5p, -184, and -339-3p associated with insulin levels and HOMA2-IR, and hsa-miR-148a-3p, -15b-3p, -93-3p, -146b-5p, -221-3p, -18a-3p, -642a-5p, and -181-2-3p associated with HbA1c levels. The targets of hsa-miR-146b-5p that correlated with its levels were enriched in inflammatory pathways, and the targets of hsa-miR-221-3p were enriched in insulin signaling and T2D pathways. These pathways showed indications of co-regulation by HbA1c-associated miRNAs. There were significant differences in the microRNA profiles associated with glucose, insulin, or HOMA-IR compared to those associated with HbA1c. The HbA1c-associated miRNAs also correlated with the expression of target mRNAs in pathways important to the development of T2D.

17 February 2019 in Annals of Medicine
Verified
Journal Article
Closed access
JHJussi A. Hernesniemi
Jussi A. Hernesniemi
SMShadi Mahdiani
Shadi Mahdiani
JTJuho A. Tynkkynen
Juho A. Tynkkynen
LLLeo-Pekka Lyytikäinen
Leo-Pekka Lyytikäinen
PMPashupati P. Mishra
Pashupati P. Mishra
NONiku Oksala
Niku Oksala
Objective: Investigation of the clinical potential of extensive phenotype data and machine learning (ML) in the prediction of mortality in acute coronary syndrome (ACS). Methods: The value of ML and extensive clinical data was analyzed in a retrospective registry study of 9066 consecutive ACS patients (January 2007 to October 2017). Main outcome was six-month mortality. Prediction models were developed using two ML methods, logistic regression and extreme gradient boosting (xgboost). The models were fitted in training set of patients treated in 2007–2014 and 2017 (81%, n = 7344) and validated in a separate validation set of patients treated in 2015–2016 with full GRACE score data available for comparison of model accuracy (19%, n = 1722). Results: Overall, six-month mortality was 7.3% (n = 660). Several variables were found to be significantly associated with six-month mortality by both ML methods. The xgboost scored the best performance: AUC 0.890 (0.864–0.916). The AUC values for logistic regression and GRACE score were 0.867(0.837–0.897) and 0.822 (0.785–0.859), respectively. The AUC value of xgboost was better when compared to logistic regression (p = .012) and GRACE score (p < .00001). Conclusions: The use of extensive phenotype data and novel machine learning improves prediction of mortality in ACS over traditional GRACE score.